Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
Yang CaoJiao Guo

Abstract

This study is to investigate the cholesterol-lowering effect and the new mode of action of coptis alkaloids on high lipid diet-induced hyperlipidemic rats. Coptis alkaloids extract (CAE) was prepared by alcohol extraction from Rhizoma Coptidis that have been quality-controlled according to the protocol. The cholesterol-lowering effect of CAE was evaluated on SD rats fed with high-lipid diet. Serum level of lipid, Bile acid and cholesterol in the liver and feces of the rats were measured using colorimetric assay kit. RT-PCR and Western blot were used to analyze the mRNA and protein expression of cholesterol metabolism-related genes including cholesterol 7α-hydroxylase (CYP7A1), peroxisome proliferator-activated receptor-alpha (PPARα) and farnesoid X receptor (FXR) in the livers of the rats. A HPLC analysis was used to assess the activity of CYP7A1. The results showed that CAE reduced the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C). CYP7A1 gene expression and its activity was up-regulated dose-dependently accompanying with the increased level of bile acid and the reduced cholesterol level in the livers of the CAE treated hyperlipidemic rats. Meanwhile, the mRNA expressio...Continue Reading

References

Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D A KleinsekJ W Porter
Jun 27, 2000·The Journal of Biological Chemistry·M C HuntS E Alexson
Jan 25, 2003·Annual Review of Biochemistry·David W Russell
Sep 6, 2003·Lancet·Paul Durrington
Dec 20, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·Guorong XuGerald Salen
Feb 2, 2010·Journal of Ethnopharmacology·Bing-Liang MaYang Yang
Feb 15, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tiangang LiJohn Y L Chiang
Apr 5, 2011·European Journal of Pharmacology·Shi-Fen DongJian-Ning Sun

❮ Previous
Next ❯

Citations

Oct 14, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Zipeng GongYajie Wang
Aug 12, 2014·BioMed Research International·Tung-Ting ShamShun-Wan Chan
Jun 5, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Hao WuJie Pang
Oct 25, 2016·Frontiers in Pharmacology·Hui-Li TanBey-Hing Goh
Feb 17, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Qingshan ZhangRenbatu Bu
Feb 6, 2020·Experimental and Therapeutic Medicine·Pingping FengHongbo Shen
Aug 18, 2018·Experimental and Therapeutic Medicine·Jianbo HuangZhaohuan Lou
Feb 23, 2020·International Journal of Molecular Sciences·Estera OkonAnna Wawruszak
May 18, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Kyungjin Lee, Ho-Young Choi
May 31, 2019·Journal of Cellular and Molecular Medicine·Chiakang HoQingfeng Li
Feb 6, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Lijuan ZhaoXiaobo Li
Apr 21, 2020·Current Pharmaceutical Design·Mervin Chávez-CastilloManuel Velasco
Apr 4, 2021·International Journal of Molecular Sciences·Giuseppe ManninoCarla Gentile
Aug 8, 2021·International Journal of Molecular Sciences·Oh-Jun KwonByung-Cheol Lee
Dec 29, 2018·Journal of Agricultural and Food Chemistry·Ghulam Shere RazaKarl-Heinz Herzig
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fengling WangWeidong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.